Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
35.35
-1.77 (-4.77%)
At close: Jun 16, 2026, 4:00 PM EDT
35.99
+0.64 (1.81%)
After-hours: Jun 16, 2026, 4:10 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.78 billion as of June 16, 2026. Its market cap has increased by 694.90% in one year.
Market Cap
1.78B
Enterprise Value
1.83B
1-Year Change
694.90%
Ranking
Category
Stock Price
$35.35
Market Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.78B, an increase of 224.74%. That is a compound annual growth rate of 23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.78B | 60.98% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 1.84B |
| Rapport Therapeutics | 1.84B |
| Biohaven | 1.82B |
| Stoke Therapeutics | 1.82B |
| Mesoblast | 1.79B |
| Nuvation Bio | 1.78B |
| Nurix Therapeutics | 1.77B |
| Viridian Therapeutics | 1.76B |